NL-OMON28196招募中不适用
Acetylcysteine in Patients With Sickle Cell Disease: Reducing the Incidence of Daily Life Pain.
Academic Medical Center, Amsterdam0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 140
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age 12 years or older;
- •2. Sickle cell disease, either homozygous sickle cell disease (HbSS), compound heterozygous sickle cell disease (HbSC), HbSβ0 or HbSβ+ thalassemia;
排除标准
- •1. Chronic blood transfusion or transfusion in the preceding 3 months;
- •2. Painful crisis in the last 4 weeks (with respect to the moment of inclusion);
研究者
相似试验
进行中（未招募）
1 期
Acetylcysteine in patients with Sickle Cell Disease: Reducing the incidence of daily life pain in patients with sickle cell diseaseSickle CellMedDRA version: 15.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004850EUCTR2012-004892-37-NLAcademic Medical Center140
进行中（未招募）
不适用
Acetylcysteine in patients with Sickle Cell Disease: Reducing the incidence of daily life pain in patients with sickle cell diseaseMedDRA version: 17.1Level: LLTClassification code 10002077Term: Anaemia sickle cellSystem Organ Class: 100000004850MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851Sickle Cell DiseaseEUCTR2012-004892-37-GBAcademic Medical Center, Department of Haematology, University of Amsterdam140
进行中（未招募）
1 期
Acetylcysteine in patients with Sickle Cell Disease: Reducing the incidence of daily life pain in patients with sickle cell diseaseEUCTR2012-004892-37-BEAcademic Medical Center140
已完成
不适用
AcetylCysteine in the treatment of Sickle Cell DiseaseSickle cell diseaseISRCTN28828586CURAMA Study Group (The Netherlands)10
尚未招募
不适用
Acetylcysteine In The Treatment of Sickle Cell Diseasesickle cell disease (anemia), hypoxia-reperfusion injury, endothelial damage, oxidative stress, NO-availability, inflammation, sikkelcelziekte, chronische ontsteking, endotheelschade.NL-OMON2309010